 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
With $1.5M in New Financing, DioGenix Starts Prospective Trial of Targeted Sequencing-based MS Test
January 02, 2013
With $1.5M in New Financing, DioGenix Starts Prospective Trial of Targeted Sequencing-based MS Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- DioGenix Raises $1.5M for Clinical Trial of MS Test
December 18, 2012 / GenomeWeb Daily News - Genoptix Offers Targeted Sequencing on Ion PGM to Guide Treatment Decisions for Metastatic Melanoma
March 28, 2012 / Clinical Sequencing News - Genoptix Says NGS Melanoma Test Will Not Be Used to Place Patients in Trials for Parent Novartis
March 28, 2012 / Pharmacogenomics Reporter - University of Groningen Working to Replace Sanger-based Tests with Targeted Sequencing
April 24, 2013 / Clinical Sequencing News - Cynvenio Offering NGS Analysis of Isolated Circulating Tumor Cells Using AmpliSeq Panel
April 10, 2013 / Clinical Sequencing News